SB431542 - ≥98%, high purity , CAS No.301836-41-9, Inhibitor of activin A receptor type 1C;Inhibitor of transforming growth factor beta receptor 1

Item Number
S125924
Grouped product items
SKUSizeAvailabilityPrice Qty
S125924-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$94.90
S125924-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$355.90
S125924-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$664.90

ALK inhibitor

Basic Description

Synonyms4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide | 4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE | SB431542 | SB-431542 | 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide | SB 431542
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsSB 431542 is a small molecule that acts as a specific and selective inhibitor of TGFβ RI, ACTR-IB and ACTR-IC (transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, 5, and 7). Renal carcinoma studies have demon
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of activin A receptor type 1C;Inhibitor of transforming growth factor beta receptor 1
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases.
A specific and selective inhibitor of TGF-β type I ALK receptors and Smad3.

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type-1 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACVR1C Tbio Activin receptor type-1C (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGF1R Tclin Insulin-like growth factor I receptor (8605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBA4A Tchem Tubulin alpha-1 chain (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2A1 Tchem Casein kinase II alpha (3512 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK3 Tchem Death-associated protein kinase 3 (2108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK11 Tchem MAP kinase p38 beta (2785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKACB Tchem cAMP-dependent protein kinase beta-1 catalytic subunit (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K6 Tchem Dual specificity mitogen-activated protein kinase kinase 6 (1284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MYLK Tchem Myosin light chain kinase, smooth muscle (1267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1G1 Tchem Casein kinase I gamma 1 (2496 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STK3 Tchem Serine/threonine-protein kinase MST2 (3069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK2B Tchem CaM kinase II beta (1626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K3 Tchem Dual specificity mitogen-activated protein kinase kinase 3 (632 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase, alpha-2 subunit (1328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK2 Tchem Death-associated protein kinase 2 (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA4 Tchem Ribosomal protein S6 kinase alpha 4 (2104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PKN2 Tchem Protein kinase N2 (1991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSK Tchem Tyrosine-protein kinase CSK (2395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA5 Tchem Ribosomal protein S6 kinase alpha 5 (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCE Tchem Protein kinase C epsilon (1520 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD3 Tchem Protein kinase C nu (2315 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD1 Tchem Protein kinase C mu (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA6 Tchem Ribosomal protein S6 kinase alpha 6 (2027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15B Tchem Arachidonate 15-lipoxygenase, type II (7244 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PIK3CA PI3-kinase p110-alpha subunit (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkcd Protein kinase C delta (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr4 Fibroblast growth factor receptor 4 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Camk2g CaM kinase II gamma (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tec Tyrosine-protein kinase TEC (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Schistosoma mansoni (6170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lef Anthrax lethal factor (7585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GCN5 Histone acetyltransferase GCN5 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Luciferin 4-monooxygenase (66902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapt Microtubule-associated protein tau (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Impa1 Inositol monophosphatase 1 (16203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tgfbr1 TGF-beta receptor type-1 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide
INCHI InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)
InChi Key FHYUGAJXYORMHI-UHFFFAOYSA-N
Canonical SMILES C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5
Isomeric SMILES C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5
PubChem CID 4521392
Molecular Weight 384.39

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeDateItem
G2430449Certificate of AnalysisJul 16, 2024 S125924
G2430450Certificate of AnalysisJul 16, 2024 S125924
G2430451Certificate of AnalysisJul 16, 2024 S125924
G2430476Certificate of AnalysisJul 16, 2024 S125924
K2125415Certificate of AnalysisSep 11, 2023 S125924
I1509074Certificate of AnalysisMar 17, 2023 S125924

Chemical and Physical Properties

SolubilitySoluble in DMSO (77 mg/ml at 25 °C), ethanol (45 mg/ml at 25 °C), DMF (~20 mg/ml), DMSO:PBS (pH 7.2) (1:1) (~ 0.5 mg/ml), and water (<1 mg/ml at 25 °C).
SensitivityHeat sensitive;light sensitive
Melt Point(°C)214 °C(dec.)

Related Documents

FAQs and Articles

Citations of This Product

1. Jinyue Zhu, Weiqing Wang, Xia Wu.  (2020)  Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1/NF-κB pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  521  (1055).  [PMID:31733831] [10.1016/j.bbrc.2019.10.178]
2. Meng Wang, Hui Li, Yaxin Zhao, Chuanfeng Lv, Guanghua Zhou.  (2019)  Rhynchophylline attenuates allergic bronchial asthma by inhibiting transforming growth factor‑β1‑mediated Smad and mitogen‑activated protein kinase signaling transductions in vivo and in vitro.  Experimental and Therapeutic Medicine,  17  (1): (251-259).  [PMID:30651790] [10.3892/etm.2018.6909]

References

1. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A et al..  (2002)  Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5)..  J Med Chem,  45  (5): (999-1001).  [PMID:11855979] [10.1021/op500134e]
2. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS.  (2002)  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7..  Mol Pharmacol,  62  (1): (65-74).  [PMID:12065756] [10.1021/op500134e]
3. Minutti CM et al..  (2019)  A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation..  Immunity,  50  (3): (645-654.e6).  [PMID:30770250]
4. Chen H et al..  (2012)  Airway epithelial progenitors are region specific and show differential responses to bleomycin-induced lung injury..  Stem Cells,  30  (9): (1948-60).  [PMID:22696116]
5. Liberti DC et al..  (2021)  Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury..  Cell Rep,  35  (6): (109092).  [PMID:33979629]
6. Salehi H et al..  (2019)  Application of Hanging Drop Culture for Retinal Precursor-Like Cells Differentiation of Human Adipose-Derived Stem Cells Using Small Molecules..  J Mol Neurosci,      [PMID:31363912]
7. André PA et al..  (2015)  BARD1 mediates TGF-ß signaling in pulmonary fibrosis..  Respir Res,  16  (118).  [PMID:26415510]
8. Kutsche LK et al..  (2018)  Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis..  Cell Syst,  (4): (438-452.e8).  [PMID:30292704]
9. Abarca-Buis R et al..  (2020)  Control of fibrosis by TGFß signalling modulation promotes redifferentiation during limited regeneration of mouse ear..  Int J Dev Biol,  64  (7-8-9): (423-432).  [PMID:33063836]
10. Keatinge M et al..  (2021)  CRISPR gRNA phenotypic screening in zebrafish reveals pro-regenerative genes in spinal cord injury..  PLoS Genet,  17  (4): (e1009515).  [PMID:33914736]
11. Konishi S et al..  (2022)  Defined conditions for long-term expansion of murine and human alveolar epithelial stem cells in three-dimensional cultures..  STAR Protoc,  (2): (101447).  [PMID:35712012]
12. Xiang Y et al..  (2020)  Dysregulation of BRD4 Function Underlies the Functional Abnormalities of MeCP2 Mutant Neurons..  Mol Cell,  79  (84-98.e9).  [PMID:32526163]
13. Zong W et al..  (2015)  Estradiol plays a role in regulating the expression of lysyl oxidase family genes in mouse urogenital tissues and human Ishikawa cells..  J Zhejiang Univ Sci B,  16  (10): (857-64).  [PMID:26465133]
14. .  (1991)  From the Centers for Disease Control. AIDS Clinical Trials Information Service..  JAMA,  266  (13): (1756).  [PMID:1653860]
15. Teisanu RM et al..  (2011)  Functional analysis of two distinct bronchiolar progenitors during lung injury and repair..  Am J Respir Cell Mol Biol,  44  (6): (794-803).  [PMID:20656948]
16. Xiang Y et al..  (2018)  Generation and Fusion of Human Cortical and Medial Ganglionic Eminence Brain Organoids..  Curr Protoc Stem Cell Biol,  47    [PMID:30854156]
17. Xiang Y et al..  (2020)  Generation of Regionally Specified Human Brain Organoids Resembling Thalamus Development..  STAR Protoc,    [PMID:33103124]
18. Xiang Y et al..  (2019)  hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids..  Cell Stem Cell,  24  (3): (487-497.e7).  [PMID:30799279]
19. Wimmer RA et al..  (2019)  Human blood vessel organoids as a\xa0model of\xa0diabetic vasculopathy..  Nature,  565  (7740): (505-510).  [PMID:30651639]
20. Katsura H et al..  (2020)  Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction..  Cell Stem Cell,  27  (6): (890-904.e8).  [PMID:33128895]
21. Malaguti M et al..  (2019)  Id1 Stabilizes Epiblast Identity by Sensing Delays in Nodal Activation and Adjusting the Timing of Differentiation..  Dev Cell,  50  (4): (462-477.e5).  [PMID:31204172]
22. Khanam R et al..  (2022)  Identification of Adamts4 as a novel adult cardiac injury biomarker with therapeutic implications in patients with cardiac injuries..  Sci Rep,  12  (9898).  [PMID:35701493]
23. Ashja-Arvan M et al..  (2020)  Impact of IFN-ß and LIF overexpression on human adipose-derived stem cells properties..  J Cell Physiol,      [PMID:32324266]
24. Kim D et al..  (2015)  Impaired osteogenesis in Menkes disease-derived induced pluripotent stem cells..  Stem Cell Res Ther,  (160).  [PMID:26347346]
25. Sabate-Soler S et al..  (2022)  Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality..  Glia,  70  (7): (1267-1288).  [PMID:35262217]
26. Xu M et al..  (2021)  MicroRNA-17-5p restrains the dysfunction of Ang-II induced podocytes by suppressing secreted modular calcium-binding protein 2 via NF-κB and TGFβ signaling..  Environ Toxicol,  36  (7): (1402-1411).  [PMID:33835671]
27. Liu H et al..  (2022)  MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis..  Bioengineered,  13  (4): (9613-9627).  [PMID:35412956]
28. Zhu K et al..  (2014)  MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells..  Sci Rep,  (5524).  [PMID:25027009]
29. Hargus G et al..  (2014)  Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain..  Cell Rep,  (6): (1697-703).  [PMID:25220454]
30. Zhang M et al..  (2022)  Prkg2 regulates alveolar type 2-mediated re-alveolarization..  Stem Cell Res Ther,  13  (111).  [PMID:35313961]
31. Ateaque S et al..  (2022)  Selective activation and down-regulation of Trk receptors by neurotrophins in human neurons co-expressing TrkB and TrkC..  J Neurochem,  161  (6): (463-477).  [PMID:35536742]
32. Esteves TC et al..  (2011)  Somatic cell nuclear reprogramming of mouse oocytes endures beyond reproductive decline..  Aging Cell,  10  (80-95).  [PMID:20969722]
33. Yang YH et al..  (2016)  Stromal Tissue Rigidity Promotes Mesenchymal Stem Cell-Mediated Corneal Wound Healing Through the Transforming Growth Factor ß Signaling Pathway..  Stem Cells,  34  (10): (2525-2535).  [PMID:27250866]
34. Kelly TJ et al..  (2019)  Temporal Control of the TGF-ß Signaling Network by Mouse ESC MicroRNA Targets of Different Affinities..  Cell Rep,  29  (9): (2702-2717.e7).  [PMID:31775039]
35. Kang Y et al..  (2016)  Transforming Growth Factor-ß Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors..  Clin Cancer Res,  22  (19): (4934-4946).  [PMID:27126993]
36. Epping MT et al..  (2015)  TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFß signaling activation..  Cell Death Differ,  22  (8): (1353-62).  [PMID:25613376]
37. Jinyue Zhu, Weiqing Wang, Xia Wu.  (2020)  Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1/NF-κB pathway.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  521  (1055).  [PMID:31733831] [10.1016/j.bbrc.2019.10.178]
38. Meng Wang, Hui Li, Yaxin Zhao, Chuanfeng Lv, Guanghua Zhou.  (2019)  Rhynchophylline attenuates allergic bronchial asthma by inhibiting transforming growth factor‑β1‑mediated Smad and mitogen‑activated protein kinase signaling transductions in vivo and in vitro.  Experimental and Therapeutic Medicine,  17  (1): (251-259).  [PMID:30651790] [10.3892/etm.2018.6909]

Solution Calculators